CSL Behring

Activity by year

2017201820192020202120222023202420252026

ContractExpansion

Sep 12, 2019EXPANSIONMarburg, Germany$203.0M50 jobsops 2023
CSL Behring plans €185M expansion in Marburg, Germany
CSL Behring announced a €185 million expansion of its facility in Marburg, Germany, to increase production capacity for hereditary angioedema treatments, expected to be completed in 2023, creating 50 jobs.
CSL Behring #Medical Devices csl.com
Dec 11, 2017CONTRACTBroadmeadows, Victoria, Australia
CSL Behring signs nine-year plasma supply agreement with National Blood Authority
CSL Behring signed a new National Fractionation Agreement with the National Blood Authority of Australia to supply plasma-derived therapies manufactured at its Broadmeadows facility. The agreement runs from 1 January 2018 to 31 December 2026.
CSL Behring National Blood Authority customer newsroom.csl.com

Site	Largest	Latest
Marburg, Germany	$203.0M	2019-09-12

Customers

Loading…